CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

INJ Price Prediction: Neckline Slip Puts Martinez's $13.40 Bull Case on Hold

Blockchain.News logo

Published on

Add as a preferred source on Google
INJ Price Prediction: Neckline Slip Puts Martinez's $13.40 Bull Case on Hold

Injective (INJ) is trading at $7.07 on Binance spot as of October 10, 2026, already below the $7.33 level that analyst Ali Martinez identified on October 5 as the threshold buyers must defend for a...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

On October 5, Ali Martinez (@alicharts, via cryptoworld.club) outlined a conditional bull case: "If buyers defend that level and momentum picks up, the pattern points toward $13.40," with $7.33 identified as the decisive neckline. Five days later, the condition has not been satisfied. INJ is printing $7.07 on Binance spot, 26 cents below that threshold, with a 24-hour session range of $6.84 to $7.16 and spot volume of $5.4 million. The breach does not mechanically foreclose a recovery, but the pattern trigger has not fired, and the burden of proof has shifted to buyers.

The moving average picture tells two different stories depending on the timeframe. The 7-day SMA ($7.38) and 20-day SMA ($7.60) both sit above current price, placing INJ in a short-term bearish posture. The EMA 12 ($7.34) and EMA 26 ($7.15) retain a positive spread — EMA 12 is still above EMA 26 — but with price trading below both lines, that gap is narrowing. Further out, the 50-day SMA ($6.44) and 200-day SMA ($4.97) remain well below spot, a longer-term structural context that the current weakness has not yet erased.

34. Those three levels converge within a roughly 14-cent band directly overhead, and they overlap closely with the neckline Martinez flagged.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.